Experts at the agency that regulates drugs for the European Union said Tuesday that they found a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare blood clots after a small number of cases were reported in the United States, but they confirmed the vaccine’s benefits still outweighed the very small risks of recipients developing the unusual clots.
from https://ift.tt/3dx7Wpm
Sem comentários:
Enviar um comentário